Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Short-Term Debt issuances (2016 - 2025)

Cosmos Health (COSM) has disclosed Short-Term Debt issuances for 10 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-Term Debt issuances rose 16.36% year-over-year to $6.7 million, compared with a TTM value of $27.9 million through Sep 2025, up 12.51%, and an annual FY2024 reading of $25.9 million, up 28.46% over the prior year.
  • Short-Term Debt issuances was $6.7 million for Q3 2025 at Cosmos Health, down from $7.3 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $7.3 million in Q2 2025 and bottomed at $4.3 million in Q1 2023.
  • Average Short-Term Debt issuances over 5 years is $6.0 million, with a median of $5.9 million recorded in 2024.
  • Peak annual rise in Short-Term Debt issuances hit 72044.73% in 2021, while the deepest fall reached 68.15% in 2021.
  • Year by year, Short-Term Debt issuances stood at $6.3 million in 2021, then dropped by 18.25% to $5.1 million in 2022, then increased by 16.05% to $6.0 million in 2023, then increased by 18.99% to $7.1 million in 2024, then dropped by 5.11% to $6.7 million in 2025.
  • Business Quant data shows Short-Term Debt issuances for COSM at $6.7 million in Q3 2025, $7.3 million in Q2 2025, and $6.8 million in Q1 2025.